Distance to first symptoms measured by the 6-min walking test differentiates between treatment success and failure in patients with degenerative lumbar disorders.

Publikation

Distance to first symptoms measured by the 6-min walking test differentiates between treatment success and failure in patients with degenerative lumbar disorders.

Wissenschaftlicher Artikel/Review - 11.01.2022

Zeitlberger Anna M, Sosnova Marketa, Ziga Michal, Gautschi Oliver P, Regli Luca, Bozinov Oliver, Weyerbrock Astrid, Stienen Martin N, Maldaner Nicolai

Zitation

Zeitlberger A, Sosnova M, Ziga M, Gautschi O, Regli L, Bozinov O, Weyerbrock A, Stienen M, Maldaner N. Distance to first symptoms measured by the 6-min walking test differentiates between treatment success and failure in patients with degenerative lumbar disorders. Eur Spine J 2022; 31:596-603.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Eur Spine J 2022; 31

Veröffentlichungsdatum

11.01.2022

eISSN (Online)

1432-0932

Seiten

596-603

Kurzbeschreibung/Zielsetzung

The smartphone-based 6-min walking test (6WT) is an established digital outcome measure in patients undergoing surgery for degenerative lumbar disorders (DLD). In addition to the 6WTs primary outcome measure, the 6-min walking distance (6WD), the patient's distance to first symptoms (DTFS) and time to first symptoms (TTFS) can be recorded. This is the first study to analyse the psychometric properties of the DTFS and TTFS.